Neonatal infections are a major cause of newborn mortality in low-resource settings. In view of the World Health Organization’s new 2015 guidelines for outpatient treatment of neonatal sepsis when referral is not feasible, PATH reviewed a range of drug formulation, packaging, and delivery technologies that might be applied to gentamicin delivery for infants at primary care to improve safety, ease of delivery, and potentially expand access.